Table 2.
All patients (N = 223) |
Mild–moderate disease (N = 178) |
Severe–critical disease (N = 45) |
p value | ||||
---|---|---|---|---|---|---|---|
Median or n | IQR or % | Median or n | IQR or % | Median or n | IQR or % | ||
Age | 51 | 36–62 | 48 | 33–59 | 62 | 52–71.50 | < 0.001 |
Sex (male) | 113 | 50.7% | 88 | 49.4% | 25 | 55.6% | 0.463 |
Hospitalization status | 162 | 72.6% | 117 | 65.7% | 45 | 100% | < 0.001 |
CT findings compatible with COVID-19 | 182 | 85% | 138 | 81.7% | 44 | 97.8% | 0.007 |
Days from first symptom onset to diagnosis | 3 | 0–7 | 3 | 0–7 | 3 | 1–6.5 | 0.422 |
N patient number in group, n patient number with the trait, IQR interquartile range
P value for mild disease group vs. severe disease group